STARLIGHT CARDIOVASCULAR INC
San Diego, CA · Medtech · Private
Percutaneous adjustable branch pulmonary artery blood flow restrictor device for congenital heart defects
- Grants
- $10M
- 12 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 13
- 1 granted · 12 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Ductus Arteriosus Stent To Improve Congenital Heart Defect Mortality | $492,571 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Ductus Arteriosus Stent To Improve Congenital Heart Defect Mortality | $492,571 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Development Of A Pulmonary Flow Restrictor For Hypoplastic Left Heart Syndrome | $448,000 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Development Of A Pulmonary Flow Restrictor For Hypoplastic Left Heart Syndrome | $448,000 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · Ductus Arteriosus Stent To Improve Congenital Heart Defect Mortality | $1,256,635 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · Ductus Arteriosus Stent To Improve Congenital Heart Defect Mortality | $2,158,183 | |
| Federal grant | Department of Health and Human Services · Phase II · Ductus Arteriosus Stent To Improve Congenital Heart Defect Mortality | $901,548 | |
| Federal grant | Department of Health and Human Services · Phase II · Development Of A Pulmonary Flow Restrictor For Hypoplastic Left Heart Syndrome | $999,969 | |
| Federal grant | Department of Health and Human Services · Phase II · Administrative Supplement to Promote Diversity in MedTech Through Development of Pulmonary Flow Restrictors | $88,483 | |
| Federal grant | Department of Health and Human Services · Phase II · Ductus Arteriosus Stent To Improve Congenital Heart Defect Mortality | $999,918 | |
| Federal grant | Department of Health and Human Services · Phase II · Development Of A Pulmonary Flow Restrictor For Hypoplastic Left Heart Syndrome | $999,901 | |
| Federal grant | Department of Health and Human Services · Phase II · Ductus Arteriosus Stent To Improve Congenital Heart Defect Mortality | $999,876 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1786 | COLDSTEEL LASER, INC | — | — |
| 1787 | LA JOLLA ALCOHOL RESEARCH INC | — | — |
| 1788 | Cambre Kelly | — | — |
| 1789 | STARLIGHT CARDIOVASCULAR INC | — | — |
| 1790 | AXOSIM, INC. | — | — |
| 1791 | BATANDCAT, INC. | — | — |
| 1792 | DANDELION SCIENCE CORP | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Devices And Methods For Delivering Non-balloon Expandable Implantsapplication
- Variable Diameter Stentsapplication
- Devices And Methods For Maintaining A Patent Ductus Arteriosusapplication
- Ductus Arteriosus And Septal Conduit Implants And Related Delivery Systems And Methodsapplication
- Devices And Methods For Maintaining A Patent Ductus Arteriosusgranted
- Flow Restrictorapplication
- Flow Restrictorapplication
- Ductus Arteriosus And Septal Conduit Implants And Related Delivery Systemsapplication
- Devices And Methods For Delivering Non-balloon Expandable Implantsapplication
- Variable Diameter Stentsapplication
- Stent Delivery Devices And Methodsapplication
- Variable Diameter Stentsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.